News from the FDA/CDC

Nebulized LAMA for COPD approved

A long-acting muscarinic antagonist for COPD is now available in a nebulizer form in the United States.

News from the FDA/CDC

Benralizumab approved for eosinophilic asthma

Compared with placebo, benralizumab reduced the annual asthma exacerbation rate in eosinophilic asthma patients by up to 51%.